Navigation Links
Cepheid to Webcast Analyst Event
Date:7/21/2008

Management presentations to be hosted at 2008 American Association for

Clinical Chemistry Annual Meeting

SUNNYVALE, Calif., July 21 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) today invited investors to participate in the Company's Analyst Reception which is being hosted in Washington, D.C. ahead of the 2008 American Association for Clinical Chemistry (AACC) Annual Meeting.

Cepheid speakers will include Chief Executive Officer John Bishop, Chief Medical and Technology Officer David Persing, Chief Operations Officer Humberto Reyes, Senior Vice President of Worldwide Commercial Operations, Rob Koska, and Chief Financial Officer Andrew Miller.

Investors and interested parties are welcome to access the live webcast that will be available starting at 5:30 p.m. Eastern Time on Monday, July 28, 2008. The program is expected to last up to three hours. To access the live webcast, please visit Cepheid's website at http://www.cepheid.com/investors at least 15 minutes before the scheduled start time to download any necessary audio or plug-in software. A replay of the webcast will be available shortly following the call and will remain available for at least 90 days.

About Cepheid

Cepheid (Nasdaq: CPHD), based in Sunnyvale, Calif., is an on-demand molecular diagnostics company that develops, manufactures, and markets fully-integrated systems and tests for genetic analysis in the clinical, industrial and biothreat markets. The Company's systems enable rapid, sophisticated genetic testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. Cepheid's easy-to-use systems integrate a n
'/>"/>

SOURCE Cepheid
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Cepheid Schedules Fiscal 2008 Second Quarter Financial Results Announcement and Webcast
2. Noted Molecular Epidemiologist Joins Cepheid to Head Healthcare Associated Infection Consortium Program
3. Cepheid Market Reach Extended with Licenses in Canada and Registrations in Mexico
4. Cepheid Signs Group Purchasing Contract with Novation, the Nations Largest Healthcare Contracting Organization
5. Cepheid to Present at the Robert W. Baird Growth Stock Conference and the Bank of America Healthcare Conference
6. Cepheid Schedules Teleconference and Webcast for First Quarter 2008 Results
7. Cepheid to Present at Cowen and Companys 28th Annual Healthcare Conference
8. Cepheid Reports Fourth Quarter and Full Year 2007 Results
9. Cepheid and Instrumentation Laboratory Introduce Xpert(TM) HemosIL(R) FII & FV Assay to European Clinical Testing Market
10. Cepheid Appoints Senior VP, Chief Financial Officer to Management Team
11. Cepheid Schedules Teleconference and Webcast for 2007 Fourth Quarter and Full Year Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)... 6 BioSpecifics Technolo...ompany developing first-in-class collagenase-based...or the third quarter ended September 30, 2009. ,... this year, the FDA,s Arthritis Advisory Committee...pproval of XIAFLEX(TM) for the treatment of Dupuyt...
(Date:11/6/2009)...ov. 6 ,, 3Q09 Corp...utenza(TM) E.U. Marketing Authorization to Astella...n commercial readiness activities Expanded manage...rketing; and Director, Commercial Operations Appo... Audit Committee chairman , Upcoming 2009 M...
(Date:11/6/2009)...The agenda for Arrowhead’s 2010 Personalized... take place on February 22-24, 2010 in Philadelphi...e we will highlight key issues in forming partners...xperiences. , Minneapolis...rowhead’s 2010 Personalized Medicine Partne...
(Date:11/5/2009)...v. 5 DSM Pharmaceutical Products t...liance with Galenix, Saint Jean D,Illac, France, w...nufacturing partner for Galenix commercial product...llaborate on business development opportunities co...ed on the strength of Galenix in drug product deve...
Breaking Biology Technology:Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3
Wisconsin's unusual Internet tax stirs dissent
...nal honors on Monday as President Bush gave medals...l R. de Boor and the Wisconsin Alumni Research Fo...nology transfer, respectively. , ,The 2003 Nation... accomplishments in various fields. They included ... Ethernet, and the work that led to the first auto...
...ags "wake up" when they,re near a reader and can s..., including its history, quantity, location and co...reds of major companies are scurrying to develop s...ication (RFID) technology after fall 2003 mandates...that their suppliers be RFID-compliant, tagging ca...
Other Biology Technology:UW-Madison workgroup helps state companies tap the power of RFID 2UW-Madison workgroup helps state companies tap the power of RFID 3UW-Madison workgroup helps state companies tap the power of RFID 4
(Date:11/9/2009)...wire/ -- CBS Vision, the research division of CBS ...a Group company, today announced a new research pa...the CBS Television City research facility housed i... venture, which marries the capabilities of CBS Vi...ll be called Communications Lab@OMD . ,, CBS,s...
(Date:11/9/2009)...ytoplankton are flourishing in areas of open water...ce shelves and glaciers around the Antarctic Penin...eficial impact on climate change. As the blooms di... can store carbon for thousands or millions of yea...l Change Biology , scientists from British Antarct...
(Date:11/9/2009)...nergy (DOE) has announced plans to fund research a...hool of Engineering on technologies that would hel...ure and permanent safe storage, or sequestration, ...ration with Southern Company, the parent company o... 2009 American Recovery and Reinvestment Act, the ...
Breaking Biology News(10 mins):CBS and OMD Partner to Provide the Agency With Access to the Network's Television City Research Facility in Las Vegas 2CBS and OMD Partner to Provide the Agency With Access to the Network's Television City Research Facility in Las Vegas 3CBS and OMD Partner to Provide the Agency With Access to the Network's Television City Research Facility in Las Vegas 4Antarctica glacier retreat creates new carbon dioxide store 2UAB, partners seek safe carbon dioxide storage for 'greener' power generation 2UAB, partners seek safe carbon dioxide storage for 'greener' power generation 3Mersana Reports Preliminary Phase 1 Results of XMT 1001 in Patients with Advanced Solid Tumors 12387 1Mersana Reports Preliminary Phase 1 Results of XMT 1001 in Patients with Advanced Solid Tumors 12387 2Mersana Reports Preliminary Phase 1 Results of XMT 1001 in Patients with Advanced Solid Tumors 12387 3AGA Institute and Horizon Therapeutics Launch Connect to Protect Program to Educate Physicians and Consumers on Risks Associated With NSAID Use 12385 1AGA Institute and Horizon Therapeutics Launch Connect to Protect Program to Educate Physicians and Consumers on Risks Associated With NSAID Use 12385 2AGA Institute and Horizon Therapeutics Launch Connect to Protect Program to Educate Physicians and Consumers on Risks Associated With NSAID Use 12385 3UCB and Crohns Disease Working Group Award 24175 000 in Research Grants to Gastroenterology Fellows 12383 1UCB and Crohns Disease Working Group Award 24175 000 in Research Grants to Gastroenterology Fellows 12383 2
...ew research published online this week in the open...ic and much-studied question in the fruit fly, and...ls, male or female development depends on the pres...ales because it includes masculinizing genes. But .... James Erickson and Jerome Quintero at Texas A&M ...
...p to 20 meters long and weighing as much as 20 ton...don typus) its name. Known as the gentle giant fo...broad, flattened head and minute teeth, eats tiny ...ill-rakers. Listed as a rare species, relatively ...tropical and warm seas, including the western Atla...
... new targeted screening strategy could make the di...ble in low-resource settings, concludes a new stud...cess journal PLoS Neglected Tropical Diseases. , ...causes Chagas disease, is transmitted by triatomin... disease, which infects an estimated 11 million pe...
Other Biology News:Photo-monitoring whale sharks 2New screening strategy for detection of chagas disease in children 2
...IRsolution software provides quick and easy operat...-based control. The software is fully secure and ...lations, and compatible with user-created macros f...nables use in high-level research and development ...
Mouse Anti-Xenopus laevis Xenopus nuclear factor Antibody, Unconjugated from Developmental Studies Hybridoma Bank
...The PerkinElmer kit provides reagents for immune c...xes in serum and plasma samples using a combinatio...ized and transferred to microplate wells which are...tibody to HIV-1 p24. The immobilized monoclonal an...
Mitochondria Isolation Kit for Tissue and Cultured Cells from BioChain
Biology Products: